Metabolic-associated Fatty Liver Disease
Open Access
- 9 November 2021
- journal article
- editorial
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2021.00439
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- MAFLD and risk of CKDMetabolism, 2020
- Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north AfricaThe Lancet Gastroenterology & Hepatology, 2020
- The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver diseaseThe Lancet Gastroenterology & Hepatology, 2020
- Redefining fatty liver disease: an international patient perspectiveThe Lancet Gastroenterology & Hepatology, 2020
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International, 2020
- From NAFLD to MAFLD: a “redefining” moment for fatty liver diseaseChinese Medical Journal, 2020
- From NAFLD to MAFLD: when pathophysiology succeedsNature Reviews Gastroenterology & Hepatology, 2020
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseGastroenterology, 2020
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030Journal of Hepatology, 2018